Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Boston Scientific's other long-term assets for the quarter that ended in Jun. 2026 was CHF4,247 Mil.
Boston Scientific's quarterly other long-term assets
increased
from Dec. 2025 (CHF4,416 Mil) to Mar. 2026 (CHF4,729 Mil) but then
stayed the same
from Mar. 2026 (CHF4,729 Mil) to Jun. 2026 (CHF4,247 Mil).
Boston Scientific's annual other long-term assets
increased
from Dec. 2023 (CHF3,910 Mil) to Dec. 2024 (CHF4,821 Mil) but then
declined
from Dec. 2024 (CHF4,821 Mil) to Dec. 2025 (CHF4,416 Mil).
Boston Scientific Other Long Term Assets Historical Data
* Premium members only.
The historical data trend for Boston Scientific's Other Long Term Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.
What does a Other Long Term Assets of CHF4,247 Mil mean?
Boston Scientific (XSWX:BSX) has a Other Long Term Assets of CHF4,247 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Boston Scientific and its competitors.
Is Boston Scientific's Other Long Term Assets too high?
Boston Scientific's current Other Long Term Assets is CHF4,247 Mil. Overall, Boston Scientific has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Other Long Term Assets compare to EW and DXCM?
Boston Scientific's Other Long Term Assets of CHF4,247 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Medical Devices & Instruments company?
A good Other Long Term Assets depends on the Medical Devices & Instruments industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Boston Scientific and its competitors. Boston Scientific's current Other Long Term Assets is CHF4,247 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Boston Scientific (XSWX:BSX) has a current Other Long Term Assets of CHF4,247 Mil. The stock's GF Value™ is CHF86.18, compared to a current price of CHF38.44 — trading 55.4% below its estimated fair value. The current Other Long Term Assets is CHF4,247 Mil. Boston Scientific's overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Boston Scientific (XSWX:BSX), the current Other Long Term Assets is CHF4,247 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Boston Scientific (XSWX:BSX) Overvalued in 2026?
Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued.
The current stock price of CHF38.44 is trading 55.4% below its estimated GF Value™ of CHF86.18.
Key valuation signals for XSWX:BSX:
Other Long Term Assets: CHF4,247 Mil
GF Value™: CHF86.18 vs. price of CHF38.44 (55.4% below fair value)
No single metric tells the full story. See the XSWX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
77GF Score
Get the complete analysis for XSWX:BSX
Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:BSX has been successfully added to your 
